These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Excessive Neutrophils and Neutrophil Extracellular Traps in COVID-19. Wang J; Li Q; Yin Y; Zhang Y; Cao Y; Lin X; Huang L; Hoffmann D; Lu M; Qiu Y Front Immunol; 2020; 11():2063. PubMed ID: 33013872 [No Abstract] [Full Text] [Related]
5. Neutrophil extracellular traps in COVID-19. Zuo Y; Yalavarthi S; Shi H; Gockman K; Zuo M; Madison JA; Blair C; Weber A; Barnes BJ; Egeblad M; Woods RJ; Kanthi Y; Knight JS JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32329756 [TBL] [Abstract][Full Text] [Related]
7. The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19). Arcanjo A; Logullo J; Menezes CCB; de Souza Carvalho Giangiarulo TC; Dos Reis MC; de Castro GMM; da Silva Fontes Y; Todeschini AR; Freire-de-Lima L; Decoté-Ricardo D; Ferreira-Pereira A; Freire-de-Lima CG; Barroso SPC; Takiya C; Conceição-Silva F; Savino W; Morrot A Sci Rep; 2020 Nov; 10(1):19630. PubMed ID: 33184506 [TBL] [Abstract][Full Text] [Related]
8. The Emerging Role of Neutrophils in the Pathogenesis of Thrombosis in COVID-19. Iliadi V; Konstantinidou I; Aftzoglou K; Iliadis S; Konstantinidis TG; Tsigalou C Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065210 [TBL] [Abstract][Full Text] [Related]
9. Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy. Mastellos DC; Pires da Silva BGP; Fonseca BAL; Fonseca NP; Auxiliadora-Martins M; Mastaglio S; Ruggeri A; Sironi M; Radermacher P; Chrysanthopoulou A; Skendros P; Ritis K; Manfra I; Iacobelli S; Huber-Lang M; Nilsson B; Yancopoulou D; Connolly ES; Garlanda C; Ciceri F; Risitano AM; Calado RT; Lambris JD Clin Immunol; 2020 Nov; 220():108598. PubMed ID: 32961333 [TBL] [Abstract][Full Text] [Related]
10. Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment. Cicco S; Cicco G; Racanelli V; Vacca A Mediators Inflamm; 2020; 2020():7527953. PubMed ID: 32724296 [TBL] [Abstract][Full Text] [Related]
11. Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19. Ng H; Havervall S; Rosell A; Aguilera K; Parv K; von Meijenfeldt FA; Lisman T; Mackman N; Thålin C; Phillipson M Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):988-994. PubMed ID: 33267662 [TBL] [Abstract][Full Text] [Related]
15. Role of neutrophils, platelets, and extracellular vesicles and their interactions in COVID-19-associated thrombopathy. Caillon A; Trimaille A; Favre J; Jesel L; Morel O; Kauffenstein G J Thromb Haemost; 2022 Jan; 20(1):17-31. PubMed ID: 34672094 [TBL] [Abstract][Full Text] [Related]
16. Preventing the development of severe COVID-19 by modifying immunothrombosis. Morris G; Bortolasci CC; Puri BK; Olive L; Marx W; O'Neil A; Athan E; Carvalho A; Maes M; Walder K; Berk M Life Sci; 2021 Jan; 264():118617. PubMed ID: 33096114 [TBL] [Abstract][Full Text] [Related]
17. Mast Cells in Alveolar Septa of COVID-19 Patients: A Pathogenic Pathway That May Link Interstitial Edema to Immunothrombosis. Motta Junior JDS; Miggiolaro AFRDS; Nagashima S; de Paula CBV; Baena CP; Scharfstein J; de Noronha L Front Immunol; 2020; 11():574862. PubMed ID: 33042157 [TBL] [Abstract][Full Text] [Related]
18. Neutrophil extracellular traps induce persistent lung tissue damage via thromboinflammation without altering virus resolution in a mouse coronavirus model. Salzmann M; Gibler P; Haider P; Brekalo M; Plasenzotti R; Filip T; Nistelberger R; Hartmann B; Wojta J; Hengstenberg C; Podesser BK; Kral-Pointner JB; Hohensinner PJ J Thromb Haemost; 2024 Jan; 22(1):188-198. PubMed ID: 37748582 [TBL] [Abstract][Full Text] [Related]